UNSPSC 85581613: Removal of intraluminal device from mouth and throat, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to removal of intraluminal device from mouth and throat, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0CPY3DZ

UNSPSC 85581613 Removal of intraluminal device from mouth and throat, percutaneous approach is a Commodity code that shows minimal alignment with state and local procurement activity. The code's clinical specificity—a surgical procedure to extract objects from the mouth and throat using a percutaneous (through-skin) technique—does not match the kinds of services state and local governments are actually buying under this code designation. The recent opportunities posted under this code span occupational medical surveillance, pharmacy benefit management, temporary health professional staffing, independent medical evaluations for pension disability determinations, surgical benefit carve-outs for employee health plans, and emergency medical services for detained youth. None of these activities involve intraluminal device removal or percutaneous procedures.

The source reveals no recent state and local procurement activity that is genuinely soliciting intraluminal device-removal services or related procedural capabilities. The mismatch suggests the code may be applied inconsistently or incorrectly by issuing bodies tagging broader health services work—occupational health programs, pharmacy administration, temporary clinical staffing, and employee health benefits—under this narrow Commodity designation. Business development professionals evaluating opportunities under this code should verify the actual scope of work described in the RFP, RFQ, or IFB itself, as the UNSPSC tag does not reflect what is being purchased. The geographic spread of the six recent opportunities spans Arizona, California, Washington State, Texas, and Florida, covering municipal, county, state, and health system buyers, but none appear to relate to the code's stated clinical procedure.